U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
Apple Turns 50: From Garage Startup to AI Crossroads 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
NEW YORK, Oct. 13, 2016 -- Progyny, a leading digital healthcare company, today announced Karin Ajmani, president of healthcare services at Progyny, will present the abstract titled, “Employer Engagement and Education Increases Access to Care and eSET Utilization,” at the American Society for Reproductive (ASRM) Medicine 2016 Scientific Congress in Salt Lake City. The presentation will showcase results from companies that launched Progyny’s fertility benefits plan in January 2016. The abstract will be presented on Monday, October 17, 2016 at 11:15AM MT.
The presentation will highlight the significance of educating employers on best practices for assisted reproductive technology (ART) and clinical outcomes by providing a comprehensive benefit without restrictions on treatments or a defined dollar maximum. By providing employers with a Progyny SMART™ (Science and Member-driven Advanced Reproductive Technology) Cycle treatment plan which includes embryo assessment tools and promotion of elective Single Embryo Transfer (eSET), the company has been able to increase access to fertility care, increase pregnancy rates, and decrease multiples (twins or more) to four percent from a national average of 28 percent.
“Our goal is to eliminate the $1 billion annual healthcare costs related to high-risk maternity care, pre-term birth and NICU that stem from IVF multiples,” said Ajmani. “By giving employees access to the best technologies and utilization of eSET, we’re able to reduce the rate of twins and multiples which then reduces the overall maternity costs for the employer.”
“We are thrilled to present these results and the talented physicians in our network deserve a tremendous amount of recognition for this achievement as well,” added Gina Bartasi, CEO of Progyny. “Their partnership and leadership towards shifting the industry to single embryo transfer has been instrumental to our success.”
For more information about Progyny or to learn more the SMART cycle, visit booth #1009 at ASRM or visit www.progyny.com.
About Progyny:
Progyny is a leading digital healthcare company combining data, science and technology to provide the first end-to-end, proactive fertility solution for both large, self-insured employers and today’s informed consumer. Progyny’s SMART™ Cycle plan design comprises best-in-class research and clinical solutions, including its proprietary Eeva™ technology, to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco and Menlo Park, CA. Please visit www.progyny.com.
Media Contact: Selena Yang [email protected] Phone: 646-768-9719
